Conversion calendar in hand: management narrates the coming year as dated deliveries of business already secured
The model's full reasoning — Q3 2022 call → NOThe question asks whether management lays out a timetable of specific conversions — identified pieces of business already secured or in motion, each with timing, so the forward story reads as a schedule of things turning on. Looking at the transcript, management discusses: - CUE-101 monotherapy expansion cohort: mature median overall survival data by end of this year, potential registration trial defined mid-next year - CUE-101 + pembrolizumab combination: preliminary ORR in Q2 next year on full 20 patients, potential registration trial defined second half of year - CUE-102 dose escalation trial ongoing, data by mid-2023 - These are clinical trials, not secured business conversions The question asks about "conversions" — identified pieces of business already secured or in motion. In a biotech context, this would be like clinical trial milestones, regulatory approvals, etc. But the question specifically asks about "business" — already won, signed, awarded, ordered, booked, contracted, built, launched, closed, or already ramping. The items discussed are clinical trial data readouts and potential registration trial definitions. These are not secured business — they are contingent on data outcomes, FDA interactions, etc. The registration trials are "potential" and "being defined" — not secured. The data readouts are milestones but not conversions of secured business. The forward story is about clinical development milestones, not about secured business converting. The items are contingent on data, regulatory decisions, etc. Management says "potential registration trial being defined" — this is not a secured item. So the answer is NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ESEA | Euroseas Ltd. | Q4 2022 | 2023-02-15 | C+ |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| CPK | Chesapeake Utilities Corporation | Q3 2017 | 2017-11-10 | A |
| ESE | ESCO Technologies Inc. | Q2 2016 | 2016-05-03 | A |
CPK · Q3 2017 → YESThe question is about whether management lays out a timetable of specific conversions for the next four or so quarters, with already secured business and approximate time frames.
SOL · Q3 2022 → YESThe question is about whether management lays out a timetable of specific conversions for the next four or so quarters, with already secured items and approximate time frames.
FLL · Q3 2022 → YESThe question is about whether management lays out a timetable of specific conversions for the next four or so quarters, with already secured items and approximate time frames.